Massimo Terzolo

Orbassano, 10043, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 180 publications

Does Automated Versus Manual Ki67 Labeling Index Assessment Influence Risk Stratification in Patients with Localized Adrenocortical Carcinoma? Lessons from the ADIUVO Trial.

Does Automated Versus Manual Ki67 Labeling Index Assessment Influence Risk Stratification in Patients with Localized Adrenocortical Carcinoma? Lessons from the ADIUVO Trial.

Journal: Cancers

Published: July 06, 2026

Metyrapone-Associated Improvements in Health-Related Quality of Life in Cushing's Syndrome.

Metyrapone-Associated Improvements in Health-Related Quality of Life in Cushing's Syndrome.

Journal: European journal of endocrinology

Published: May 19, 2026

Sustained shrinkage of bilateral adrenal adenomas during long-term osilodrostat therapy.

Sustained shrinkage of bilateral adrenal adenomas during long-term osilodrostat therapy.

Journal: European journal of endocrinology

Published: April 23, 2026

Refined annexin V/PI apoptosis protocol to minimize false-positive necrotic cells.

Refined annexin V/PI apoptosis protocol to minimize false-positive necrotic cells.

Journal: New biotechnology

Published: March 31, 2026

Refined Annexin V/PI Apoptosis Protocol to Minimize False-Positive Necrotic Cells.

Refined Annexin V/PI Apoptosis Protocol to Minimize False-Positive Necrotic Cells.

Journal: New biotechnology

Published: March 31, 2026

Impact of adrenalectomy on metabolic alterations and quality of life in mild autonomous cortisol secretion: results from the randomized CHIRACIC trial.

Impact of adrenalectomy on metabolic alterations and quality of life in mild autonomous cortisol secretion: results from the randomized CHIRACIC trial.

Journal: European journal of endocrinology

Published: March 19, 2026

Targeting ER stress in adrenocortical carcinoma: Celastrol as a novel therapeutic candidate.

Targeting ER stress in adrenocortical carcinoma: Celastrol as a novel therapeutic candidate.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 16, 2025

Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study.

Temporal changes in cortisol secretion and their association with long-term outcomes in benign adrenal incidentalomas: a retrospective cohort study.

Journal: The lancet. Diabetes & endocrinology

Published: November 09, 2025

Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes-an ENSAT cohort study.

Current clinical management and outcome of patients with adrenal cortical carcinoma (ACC) with rare histological subtypes-an ENSAT cohort study.

Journal: ESMO open

Published: September 27, 2025

Germline targeted next-generation sequencing in patients with adrenal incidentalomas.

Germline targeted next-generation sequencing in patients with adrenal incidentalomas.

Journal: Frontiers in endocrinology

Published: August 13, 2025

Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion.

Endocrine and metabolic determinants of cardiometabolic risk in mild autonomous cortisol secretion.

Journal: EBioMedicine

Published: August 05, 2025

Management of cushing's syndrome in patients with adrenocortical cancer: state of the art and future perspectives.

Management of cushing's syndrome in patients with adrenocortical cancer: state of the art and future perspectives.

Journal: Reviews in endocrine & metabolic disorders

Published: July 22, 2025

Showing 1-12 of 180

Last Updated: 09/26/2026